0001555280-21-000006.txt : 20210120
0001555280-21-000006.hdr.sgml : 20210120
20210120173400
ACCESSION NUMBER: 0001555280-21-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210115
FILED AS OF DATE: 20210120
DATE AS OF CHANGE: 20210120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chen Heidi C.
CENTRAL INDEX KEY: 0001567828
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35797
FILM NUMBER: 21539644
MAIL ADDRESS:
STREET 1: C/O ZOETIS INC.
STREET 2: 100 CAMPUS DRIVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zoetis Inc.
CENTRAL INDEX KEY: 0001555280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460696167
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 973-822-7000
MAIL ADDRESS:
STREET 1: 10 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
wf-form4_161118202791394.xml
FORM 4
X0306
4
2021-01-15
0
0001555280
Zoetis Inc.
ZTS
0001567828
Chen Heidi C.
C/O ZOETIS INC.
10 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
Executive Vice President
Phantom Stock Unit
2021-01-15
4
A
0
164.3944
50.36
A
Common Stock
51.2435
4662.8029
D
These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
/s/ Katherine H. Walden, as Attorney-in-Fact
2021-01-20